# Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human Volunteers

> **NCT02963324** · PHASE1 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 12 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Ivermectin

## Key facts

- **NCT ID:** NCT02963324
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2016-12
- **Final completion:** 2017-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02963324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02963324, "Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02963324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*